Wuhan Lihe Chemical& Advanced Materials Co., Ltd.Xiaomin Huang (Sales manager) |
Member Description
Wuhan Lihe Chemical& Advanced Materials Co., Ltd. founded in April, 2013, is a national high-tech enterprise which combines the international leading research and research and the integration of science and industry.We are committed to providing one-stop services for global pharmaceutical chemical industry and new materials enterprises and research institutes, including CRO, CMO, import and export, etc.It has the most advanced technology research and development base and international first-class service team, forming the "3 + 1" platform layout with technical driving as the core.It has three technical platforms, "the research center for the quality of generic drugs" and "the center for the research of chiral asymmetric catalytic synthesis technology".Main content includes drug technology research and development, quality of generic drugs and the consistency and security research, chiral compounds customization, apis and pharmaceutical intermediates such as import and export is a body comprehensive services.The company has established close cooperation relationship with more than 1000 pharmaceutical chemical groups and research institutes including shiyao group, yangzijiang pharmaceutical group and basf.
It is our unwavering mission to build a one-stop technology service platform for medicine and chemistry in China and the world. Registration no. : 91420100066802620L Type: limited liability company (natural person investment or holding) Legal representative: peng fan Registered capital: RMB 5 million Date of establishment: April 16, 2013 Business scope: chemical raw materials and products, water-based coatings, special functional ceramic coating, resin, auxiliary products, new building materials, engineering materials, additives, industrial catalyst sales;Technical research and development and service of pharmaceutical intermediates and biological products.(the items specified in the above business scope are subject to approval or within the approved period o Member Info
Detailed Information
|